Medicus Pharma Ltd Stock Market Value
| MDCX Stock | USD 2.75 0.05 1.79% |
| Symbol | Medicus |
Medicus Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medicus Pharma's otc bb equity what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medicus Pharma.
| 11/15/2024 |
| 12/15/2024 |
If you would invest 0.00 in Medicus Pharma on November 15, 2024 and sell it all today you would earn a total of 0.00 from holding Medicus Pharma Ltd or generate 0.0% return on investment in Medicus Pharma over 30 days. Medicus Pharma is related to or competes with Dogwood Therapeutics,, Opus Genetics,, and Telix Pharmaceuticals. Medicus Pharma is traded as part of a regulated electronic trading service offered by the NASD More
Medicus Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medicus Pharma's otc bb equity current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medicus Pharma Ltd upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 16.92 | |||
| Information Ratio | 0.1268 | |||
| Maximum Drawdown | 202.1 | |||
| Value At Risk | (15.47) | |||
| Potential Upside | 20.95 |
Medicus Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medicus Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medicus Pharma's standard deviation. In reality, there are many statistical measures that can use Medicus Pharma historical prices to predict the future Medicus Pharma's volatility.| Risk Adjusted Performance | 0.1042 | |||
| Jensen Alpha | 3.66 | |||
| Total Risk Alpha | 0.1623 | |||
| Sortino Ratio | 0.2133 | |||
| Treynor Ratio | 8.47 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medicus Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Medicus Pharma Backtested Returns
Medicus Pharma is out of control given 3 months investment horizon. Medicus Pharma has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. We were able to break down twenty-nine different technical indicators, which can help you to evaluate if expected returns of 3.83% are justified by taking the suggested risk. Use Medicus Pharma Mean Deviation of 12.72, risk adjusted performance of 0.1042, and Downside Deviation of 16.92 to evaluate company specific risk that cannot be diversified away. Medicus Pharma holds a performance score of 10 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 0.44, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Medicus Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medicus Pharma is expected to be smaller as well. Use Medicus Pharma value at risk, and the relationship between the jensen alpha and skewness , to analyze future returns on Medicus Pharma.
Auto-correlation | -0.28 |
Weak reverse predictability
Medicus Pharma Ltd has weak reverse predictability. Overlapping area represents the amount of predictability between Medicus Pharma time series from 15th of November 2024 to 30th of November 2024 and 30th of November 2024 to 15th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medicus Pharma price movement. The serial correlation of -0.28 indicates that nearly 28.0% of current Medicus Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.28 | |
| Spearman Rank Test | -0.56 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Medicus Pharma lagged returns against current returns
Autocorrelation, which is Medicus Pharma otc bb equity's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medicus Pharma's otc bb equity expected returns. We can calculate the autocorrelation of Medicus Pharma returns to help us make a trade decision. For example, suppose you find that Medicus Pharma has exhibited high autocorrelation historically, and you observe that the otc bb equity is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Medicus Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medicus Pharma otc bb equity is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medicus Pharma otc bb equity is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medicus Pharma otc bb equity over time.
Current vs Lagged Prices |
| Timeline |
Medicus Pharma Lagged Returns
When evaluating Medicus Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medicus Pharma otc bb equity have on its future price. Medicus Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medicus Pharma autocorrelation shows the relationship between Medicus Pharma otc bb equity current value and its past values and can show if there is a momentum factor associated with investing in Medicus Pharma Ltd.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medicus OTC BB Equity Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.